Abstract:
The review is devoted to skin manifestations in a new coronavirus infection, information on which are continuously updated and supplemented. However, until now the available data were not systematized. The purpose of this review is to analyze dermatological manifestations with a new coronavirus infection. On average, 12.5-20.4% of patients with confirmed COVID-19 has developed cutaneous manifestations. The question of whether skin symptoms are secondary due to a respiratory infection or a primary infection of the skin itself, at this time the cop remains open. The probable mechanisms of the development of skin lesions and the role of diseases of the complement system and the state of blood hypercoagulation in the pathogenesis of their development. The review also provides clinical examples of the involvement of the skin in infectious diseases. process in COVID-19. As COVID-19 tends to be asymptomatic within 14 days after infection, skin manifestations can serve as an indicator of infection contributing to timely diagnosis.
